With the analysis among 5,740 patents, we discovered top 359 key players by total patent application. Seagen Inc., Genentech, Inc., Daiichi Sankyo Co., Ltd. are dominant in this area. They take 20.57% of the total patent filing.
Washington, United States
Patent: 501
California, United States
Patent: 347
New Jersey, United States
Patent: 333
Illinois, United States
Patent: 327
New York, United States
Patent: 314
Illinois, United States
Patent: 297
Basel-Stadt, Switzerland
Patent: 203
California, United States
Patent: 201
Cambridgeshire, United Kingdom
Patent: 180
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 126
With the analysis among 134 patents, we discovered top 16 start-ups by total patent application. Bluefin Biomedicine, Inc., Rin Institute, Inc., Institut National de la Santé et de la Recherche Médicale are active in this area.
Bluefin Biomedicine, Inc.
Massachusetts, United States
Patent: 33
Tokyo-to, Japan
Patent: 18
Institut National de la Santé et de la Recherche Médicale
Noord-Brabant, Netherlands
Patent: 13
Utrecht, Netherlands
Patent: 10
Cambridgeshire, United Kingdom
Patent: 10
Massachusetts, United States
Patent: 7
Pennsylvania, United States
Patent: 4
With the analysis among related 2,288 patents applied in the last 5 years. We discover 298 most active companies in this area. The fast-growing Seagen Inc., Daiichi Sankyo Co., Ltd., AbbVie, Inc. take 21.59% of patent filing during this period.
Washington, United States
Patent: 195
New Jersey, United States
Patent: 185
Illinois, United States
Patent: 114
Cambridgeshire, United Kingdom
Patent: 106
Magenta Therapeutics, Inc.
Massachusetts, United States
Patent: 94
Basel-Stadt, Switzerland
Patent: 79
Vaud, Switzerland
Patent: 68
California, United States
Patent: 66
New York, United States
Patent: 54
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 52
With the analysis among related 2,288 patents in last 5 years, we discover 161 new entrants. MabPlex International Co., Ltd., Sumitomo Pharmaceuticals Co., Ltd., Rin Institute, Inc. are the most active new entrants in this area.
MabPlex International Co., Ltd.
Shandong Sheng, China
Patent: 28
Sumitomo Pharmaceuticals Co., Ltd.
Osaka-fu, Japan
Patent: 21
Tokyo-to, Japan
Patent: 18
Jiangsu Hansoh Pharmaceutical Co. Ltd.
Jiangsu Sheng, China
Patent: 16
Shanghai Hansoh Biomedical Co. Ltd.
Shanghai Shi, China
Patent: 16
Cambridgeshire, United Kingdom
Patent: 14
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 13
Nanjing Levena Biopharma Co. Ltd.
Jiangsu Sheng, China
Patent: 11
Heidelberg Pharma Research GmbH
Utrecht, Netherlands
Patent: 10
With the analysis among 372 patents, we discovered top 56 universities and scientific research institutions by total patent application. The Scripps Research Institute, Rice University, Shanghai Institute of Materia Medica Chinese Academy of Sciences are dominant in this area. They take 24.73% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 38
Texas, United States
Patent: 27
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 24
Shanghai Shi, China
Patent: 18
Hovedstaden, Denmark
Patent: 15
Connecticut, United States
Patent: 12
Niedersachsen, Germany
Patent: 10
President & Fellows of Harvard College
Massachusetts, United States
Patent: 7
Academy of Military Medical Sciences
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 6